The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,029,073 in first-year total cost, median $440,461.
Most frequent study sections
- Special Emphasis Panel[ZRG1 EMNR-S (55)]6
- Special Emphasis Panel[ZRG1 EMNR-D (55)]5
- Special Emphasis Panel[ZRG1 EMNR-A (55)]1
- Special Emphasis Panel[ZRG1 EMNR-W (55)]1
Most frequent institutions
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
- CINCINNATI CHILDRENS HOSP MED CTR1
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- HUGO W. MOSER RES INST KENNEDY KRIEGER1
- INDIANA UNIVERSITY INDIANAPOLIS1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Azithromycin To Prevent BPD In Ureaplasma-Infected Preterms2R01HD067126-06A1 | TERRIN, MICHAEL LVISCARDI, ROSE MARIE | UNIVERSITY OF MARYLAND BALTIMORE, MD | $679,004 | ZRG1 |
| 2017 | Molecular basis of altered drug metabolism during pregnancy1R01HD089455-01A1 | JEONG, HYUNYOUNGWISNER, KATHERINE L | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $649,768 | ZRG1 |
| 2017 | Direct quantitation of the circulating Mtb-peptidome for pediatric TB management1R01HD090927-01A1 | HU, TONY Y. | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $440,461 | ZRG1 |
| 2017 | Mechanisms regulating KCC2 hypofunction during refractory seizures in a mouse model of ischemic neonatal seizures1R01HD090884-01A1 | KADAM, SHILPA DATTATRAY | HUGO W. MOSER RES INST KENNEDY KRIEGER, MD | $389,925 | ZRG1 |
| 2017 | Optimizing Therapeutic delivery of MicroRNAs to prevent chronic lung disease in Preterm infants.1R01HD088033-01A1 | ROGERS, LYNETTE KAY | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $329,606 | ZRG1 |
| 2017 | miRNA as a novel therapeutic target in antenatal nicotine-induced ischemic heart1R01HD088039-01A1 | XIAO, DALIAO | LOMA LINDA UNIVERSITY, CA | $327,850 | ZRG1 |
| 2016 | HYPOTHERMIA TO PREVENT NEUROTOXIC SIDE EFFECTS OF PEDIATRIC DRUGS1R01HD083001-01A1 | IKONOMIDOU, HRISSANTHI | UNIVERSITY OF WISCONSIN-MADISON, WI | $614,362 | ZRG1 |
| 2016 | Pharmacogenetics of Oxycodone, Personalized Care and Persistent Surgical Pain1R01HD089458-01 | SADHASIVAM, SENTHILKUMAR | CINCINNATI CHILDRENS HOSP MED CTR, OH | $526,410 | ZRG1 |
| 2016 | Pharmacokinetics and modeling of betamethasone therapy in threatened preterm birth1R01HD088014-01 | HAAS, DAVID M. | INDIANA UNIVERSITY INDIANAPOLIS, IN | $461,774 | ZRG1 |
| 2015 | Neonatal and Pediatric Platelet Function and Pharmacology1R01HD081281-01A1 | DIACOVO, THOMAS GDIAMOND, SCOTT L | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $535,146 | ZRG1 |
| 2015 | Pharmacokinetic and pharmacogenomic approach to indomethacin therapy in pregnancy1R01HD083003-01 | HANKINS, GARY DRYTTING, ERIK | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $416,860 | ZRG1 |
| 2015 | PBPK prediction of ontogeny mediated alteration in hepatic drug elimination1R01HD081299-01A1 | PRASAD, BHAGWAT | UNIVERSITY OF WASHINGTON, WA | $328,535 | ZRG1 |
| 2014 | Phase I and IIa trial of atorvastatin in children with acute Kawasaki disease1R01HD081296-01 | TREMOULET, ADRIANA H | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $329,372 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.